Listed at the NASDAQ Exchange
How to Open a Trading Account to Invest in How to Buy BioMarin Shares
Opening an investment account with an Online Broker is a process that is completed online and requires:
First, choose the broker that best fits you. Here, we present eToro as the primary choice.
Upload an ID and a proof of address (electricity, water bills, etc.) through the Broker's App or via email.
Whether you open it with eToro or with another broker, make sure to choose the correct base currency of the account. With some brokers, changing it once you open the account can be painful. Trading Accounts are available on US Dollars (USD), Euros (EUR), Pound Sterling (GBP), Swiss Franc (CHF), Australian Dollar (AUD) as the base currency. Practically all of them offer the option in US Dollars or Euros.
Once the Broker has approved the account, it's time to deposit cash. The depositing and withdrawing money methods are usually Credit Cards, Bank Transfers or eWallets (PayPal, PaySafe, Skrill, SafetyPay, Neteller, among others). The available options to deposit funds will depend on each Broker. A vital fact to mention is that all of the Brokers presented above allow you to use a simulator on their platform; that is, they allow testing their Demo account, which is Free. In other words, you can open a Demo account, try the platform, and then decide whether to deposit money or not.
Upon the capital is credited into your credited account, you may now buy the Stock.
Is it easy to invest in BioMarin Shares?
Online Brokers allow investing in Shares straightforwardly through optimised apps that grant easy and fast access to financial markets. Most platforms resemble a social network or any other phone app: They are designed so that the investor can learn and start trading very quickly, without the need for much prior knowledge. To buy shares of BioMarin, you have to:
open a trading account as explained before,
deposit money,
Search for "BioMarin" on the Broker's Trading platform, and
press the "Buy" button.
And, done, you are officially investing in the co's shares.
How to Buy BioMarin Stock
About BioMarin
BioMarin Pharmaceutical Inc. was founded in 1997 and is headquartered in California. A global biotechnology company develops and commercialises innovative therapies for patients with serious and life-threatening rare and ultrarare genetic diseases. The Company's portfolio consists of seven commercialised products and a fully-integrated multiple clinical and preclinical product candidates.
In 2018, BioMarin received approval from the US Food and Drug Administration (FDA) for the Palynziq® Injection, the first enzyme substitution therapy for treating phenylketonuria (PKU). In 2019, the Company announced that both the Committee for Medicinal Products for Human Use (CHMP) and the scientific committee of the European Medicines Agency (EMA) had adopted a positive opinion for the Company's marketing authorisation application for Palynziq.
